Please do not adjust margins
ChemComm
Page 4 of 5
COMMUNICATION
ChemCommun
spirooxindole products in inhibiting activity against pancreatic
lipase was elaborated.
Jin, X. Huang, Q. Ouyang, W. Du and Y.-CD.OCIh: 1e0n.1,0O3r9g/.DL0eCtCt.0,42406126H,
1
8, 872; (m) G.-Y. Ran, P. Wang, W. Du and Y.-C. Chen, Org. Chem.
We are grateful for financial support from the NSFC (Nos.
Front., 2016, 3, 861; (n) F. Wei, H.-Y. Huang, N.-J. Zhong, C.-L. Gu,
D. Wang and L. Liu, Org. Lett., 2015, 17, 1688; (o) J. Peng, G.-Y.
Ran, W. Du and Y.-C. Chen, Synthesis, 2015, 47, 2538; (p) N. J.
Zhong, F. Wei, Q. Q. Xuan, L. Liu, D. Wang and Y. J. Chen, Chem.
Commun., 2013, 49, 11071; (q) Y. Wang, L. Liu, T. Zhang, N.-J.
Zhong, D. Wang and Y.-J. Chen, J. Org. Chem., 2012, 77, 4143; (r) J.
Peng, X. Huang, L. Jiang, H.-L. Cui and Y.-C. Chen, Org. Lett., 2011,
2
1871184, 81903423, 81922070, 81973286, and 21871284),
the SMEC (2019-01-07-00-10-E00072), the SSP (20YF1449300,
and 19YF1449300), the STCSM (18401933500), and the CAS
(Nos. XDB 20020100 and QYZDY-SSW-SLH026).
Conflicts of interest
There are no conflicts to declare.
1
3, 4584.
(a) R.-J. Yan, B.-X. Liu, B.-X. Xiao, W. Du and Y.-C. Chen, Org. Lett.,
020, 22, 4240; (b) Z.-C. Chen, Z. Chen, Z.-H. Yang, L. Guo, W. Du
6
2
Notes and references
and Y.-C. Chen, Angew. Chem., Int. Ed., 2019, 58, 15021; (c) A.
Yadav, J. Banerjee, S. K. Arupula, S. M. Mobin and S. Samanta,
Asian J. Org. Chem., 2018, 7, 1595.
(a) B. Jiang, B.-X. Xiao, Q. Ouyang, H.-P. Liang, W. Du and Y.-C.
Chen, Org. Lett., 2019, 21, 3310; (b) Y.-L. Liu, X. Wang, Y.-L. Zhao,
F. Zhu, X.-P. Zeng, L. Chen, C.-H. Wang, X.-L. Zhao and J. Zhou,
Angew. Chem., Int. Ed., 2013, 52, 13735.
For selected recent reviews on the asymmetric transformation of
MBH adducts, see: (a) N.-J. Zhong, Y.-Z. Wang, L. Cheng, D. Wang
and L. Liu, Org. Biomol. Chem., 2018, 16, 5214; (b) H. Pellissier,
Tetrahedron, 2017, 73, 2831; (c) P. Xie and Y. Huang, Org. Biomol.
Chem., 2015, 13, 8578; (d) Y. Wei and M. Shi, Chem. Rev., 2013,
1
For selected reviews on spirooxindoles in new drug discovery, see:
a) Y.-T. Yang, J.-F. Zhu, G. Liao, H.-J. Xu and B. Yu, Curr. Med.
(
7
8
Chem., 2018, 25, 2233; (b) S. S. Panda, R. A. Jones, P. Bachawala
and P. P. Mohapatra, Mini-Rev. Med. Chem., 2017, 17, 1515; (c) N.
Ye, H. Chen, E. A. Wold, P.-Y. Shi and J. Zhou, ACS Infect. Dis.,
2
016, 2, 382; (d) B. Yu, Y.-C. Zheng, X.-J. Shi, P.-P. Qi and H.-M. Liu,
Anti-Cancer Agents Med. Chem., 2016, 16, 1315; (e) T. L.
Pavlovska, R. G. Redkin, V. V. Lipson and D. V. Atamanuk, Mol.
Divers., 2016, 20, 299; (f) B. Yu, D.-Q. Yu and H.-M. Liu, Eur. J.
Med. Chem., 2015, 97, 673; (g) J. J. Badillo, N. V. Hanhan and A. K.
Franz, Curr. Opin. Drug Discov. Devel., 2010, 13, 758; (h) C. V.
Galliford and K. A. Scheidt, Angew. Chem., Int. Ed., 2007, 46, 8748.
For selected reviews on the enantioselective synthesis of
spirooxindoles, see: (a) H.-Z. Gui, Y. Wei and M. Shi, Chem. - Asian
J., 2020, 15, 1225; (b) G.-J. Mei and F. Shi, Chem. Commun., 2018,
1
2
13, 6659; (e) T. Y. Liu, M. Xie and Y. C. Chen, Chem. Soc. Rev.,
012, 41, 4101.
2
9
1
G. Y. Ma and M. P. Sibi, Org. Chem. Front., 2014, 1, 1152.
0 For selected recent reviews on chiral DMAP, see: (a) Chiral
DMAP-Type Catalysts for Acyl-Transfer Reactions. In Asymmetric
Organocatalysis 1, ed. B. List, Georg Thieme Verlag, Stuttgart,
5
5
4, 6607; (c) Z. Y. Cao, F. Zhou and J. Zhou, Acc. Chem. Res., 2018,
1, 1443; (d) M. M. M. Santos, Tetrahedron, 2014, 70, 9735; (e) D.
2
012, Vol. 1; (b) C. E. Muller and P. R. Schreiner, Angew. Chem.,
Cheng, Y. Ishihara, B. Tan and C. F. Barbas, ACS Catal., 2014, 4,
43; (f) N. R. Ball-Jones, J. J. Badillo and A. K. Franz, Org. Biomol.
Int. Edit., 2011, 50, 6012; (c) L. Sun, Z. F. Zhang, F. Xie and W. B.
Zhang, Chin. J. Org. Chem., 2008, 28, 574; (d) R. P. Wurz, Chem.
Rev., 2007, 107, 5570.
7
Chem., 2012, 10, 5165.
(a) J. Peng, X. Huang, H.-L. Cui and Y.-C. Chen, Org. Lett., 2010, 12,
3
4
1
1
1 H. Waldmann, V. Khedkar, H. Duckert, M. Schurmann, I. M.
Oppel and K. Kumar, Angew. Chem., Int. Ed., 2008, 47, 6869.
2 Y. Nakamoto, F. Urabe, K. Takahashi, J. Ishihara and S.
Hatakeyama, Chem. −Eur. Chem., 2013, 19, 12653.
3 M. Shi, M. J. Qi and X. G. Liu, Chem. Commun., 2008, 44, 6025.
4 J. Peng, G. Y. Ran, W. Du and Y. C. Chen, Synthesis, 2015, 47,
4
2
260. (b) Z. C. Chen, Z. Chen, W. Du and Y. C. Chen, Chem. Rec.,
019, 19, 1.
For selected asymmetric allylic substitution of isatin-derived MBH
carbonates, see: (a) S. Paria, E. Carletti, M. Marcon, A. Cherubini-
Celli, A. Mazzanti, M. Rancan, L. Dell'Amico, M. Bonchio and X.
Companyo, J. Org. Chem., 2020, 85, 4463; (b) J. Feng, X. Li and J.-
P. Cheng, Chem. Commun., 2015, 51, 14342; (c) H. Zhang, S.-J.
Zhang, Q.-Q. Zhou, L. Dong and Y.-C. Chen, Beilstein J. Org. Chem.,
1
1
2
538.
1
1
5 Q. H. Li, G. S. Zhang, Y. H. Wang, M. S. Mei, X. Wang, Q. Liu, X. D.
Yang, P. Tian and G. Q. Lin, Org. Chem. Front., 2019, 6, 2624.
6 For selected works on thiourea for activating nitroalkenes, see:
2
012, 8, 1241; (d) X. Huang, J. Peng, L. Dong and Y.-C. Chen, Chem.
Commun., 2012, 48, 2439; (e) G.-Y. Chen, F. Zhong and Y. Lu, Org.
Lett., 2012, 14, 3955.
(
1
2
a) T. Okino, Y. Hoashi and Y. Takemoto, J. Am. Chem. Soc., 2003,
25, 12672; (b) H. Huang and E. N. Jacobsen, J. Am. Chem. Soc.,
006, 128, 7170; (c) T. Bui, S. Syed and C. F. Barbas, J. Am. Chem.
5
(a) P. K. Warghude, A. S. Sabale and R. G. Bhat, Org. Biomol.
Chem., 2020, 18, 1794; (b) J.-Q. Zhao, L. Yang, X.-J. Zhou, Y. You, Z.-
H. Wang, M.-Q. Zhou, X.-M. Zhang, X.-Y. Xu and W.-C. Yuan, Org.
Lett., 2019, 21, 660; (c) Y. Chen, B.-D. Cui, M. Bai, W.-Y. Han, N.-W.
Wan and Y.-Z. Chen, Tetrahedron, 2019, 75, 2971; (d) P. Chen, Z.-
C. Chen, Y. Li, Q. Ouyang, W. Du and Y.-C. Chen, Angew. Chem.,
Int. Ed., 2019, 58, 4036; (e) J.-Q. Zhao, L. Yang, X.-J. Zhou, Y. You,
Z.-H. Wang, M.-Q. Zhou, X.-M. Zhang, X.-Y. Xu and W.-C. Yuan,
Org. Lett., 2019, 21, 660; (f) Y. Chen, B.-D. Cui, Y. Wang, W.-Y.
Han, N.-W. Wan, M. Bai, W.-C. Yuan and Y.-Z. Chen, J. Org. Chem.,
Soc., 2009, 131, 8758.
7 Such activation mode was subsequently proved by ESI-HRMS
and NMR experiments, see the ESI.
1
1
8 (a) K. W. Quasdorf and L. E. Overman, Nature, 2014, 516, 181;
(
2
b) Y. Y. Liu, S. J. Han, W. B. Liu and B. M. Stoltz, Acc. Chem. Res.,
015, 48, 740; (c) X. P. Zeng, Z. Y. Cao, Y. H. Wang, F. Zhou and J.
Zhou, Chem. Rev., 2016, 116, 7330.
1
2
9 (a) Q. Hu, X. Q. Guan, L. L. Song, H. N. Wang, Y. Xiong, J. L. Liu, H.
Yin, Y. F. Cao, J. Hou, L. Yang and G. B. Ge, Ecotoxicol. Environ.
Saf., 2020, 192, 110305; (b) X. D. Hou, G. B. Ge, Z. M. Weng, Z. R.
Dai, Y. H. Leng, L. L. Ding, L. L. Jin, Y. Yu, Y. F. Cao and J. Hou,
Bioorg. Chem., 2018, 80, 577.
0 There are almost the same inhibiting activities for the racemic
and enantioenriched spirooxindoles. For more details, see the ESI.
2
018, 83, 10465; (g) K.-K. Wang, W. Du, J. Zhu and Y.-C. Chen,
Chin. Chem. Lett., 2017, 28, 512; (h) Q. He, W. Du and Y.-C. Chen,
Adv. Synth. Catal., 2017, 359, 3782; (i) X. Fan, H. Yang and M. Shi,
Adv. Synth. Catal., 2017, 359, 49; (j) G. Zhan, M.-L. Shi, Q. He, W.-
J. Lin, Q. Ouyang, W. Du and Y.-C. Chen, Angew. Chem., Int. Ed.,
2
016, 55, 2147; (k) K.-K. Wang, P. Wang, Q. Ouyang, W. Du and
4
|Chem. Commun., 2020, 00, 1-4
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins